Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients

ConclusionsOur data evidence that DPP-4 inhibition does not influence significantly GH/IGF-I system, confirming what was observed in animal models. Further studies  are needed to better characterize the properties of these molecules on endocrine system.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research